EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis)

Simone Francavilla, Chiara Lonati, Marco Sandri, Andrea Abate, Enrico De Marzo, Carlotta Palumbo, Lucia Aretano, Stefano Belotti, Angelo Peroni, Alessandro Peviani, Stefania Ferretti, Luigi Filippo Da Pozzo und 6 weitere

Frontiers in Urology · 2022

DOI: 10.3389/fruro.2021.796688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Urology, 2022. Verfasst von Simone Francavilla und 17 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The Immune compleX Predictive Index (iXip) is a predictive tool for prostate cancer (PCa) diagnosis that integrates PSA, PSA-IgM, prostate volume, and patient age. The aim of the study was to assess the correlation between iXip and clinically significant PCa in patients who underwent radical prostatectomy. Material and Methods A prospective multicenter study was conducted from February 2018 to August 2019 enrolling 235 patients. Stepwise-selected predictors were used to estimate multivariate regression models for each outcome, the reference model with only the set of predictors and the same model with the addition of iXip. The prediction accuracy of the two models was assessed calculating the partial area under the receiver operating characteristic curve.

Results

The ROC curve analysis showed significant differences in terms of partial area under the curve between iXip and pathological Gleason Score ≥ 7 and between iXip and tumor volume ≥ 2.5 mm 3 . The scatter plot analysis showed a positive linear correlation between iXip and tumor volume (considered as a continuous variable). The subpopulations with pT3–4 disease and cT3 disease and with positive surgical margins showed a significant linear relationship between iXip and tumor volume.

Conclusion

We found elements supporting a possible correlation between iXip and aggressive PCa in terms of Gleason Score ≥ 7 and tumor volume ≥ 2.5 mm 3 .

Zitieren

APA

Francavilla, S., Lonati, C., Sandri, M., Abate, A., Marzo, E. D., Palumbo, C., Aretano, L., Belotti, S., Peroni, A., Peviani, A., Ferretti, S., Pozzo, L. F. D., Roscigno, M., Calza, S., Guerini, A., Sigala, S., Simeone, C., & Antonelli, A. (2022). Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis). Frontiers in Urology. https://doi.org/10.3389/fruro.2021.796688

Vancouver

Francavilla S, Lonati C, Sandri M, Abate A, Marzo ED, Palumbo C, et al. Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis). Frontiers in Urology. 2022. doi:10.3389/fruro.2021.796688

BibTeX
@article{Francavilla2022,
  author = {Francavilla, Simone and Lonati, Chiara and Sandri, Marco and Abate, Andrea and Marzo, Enrico De and Palumbo, Carlotta and Aretano, Lucia and Belotti, Stefano and Peroni, Angelo and Peviani, Alessandro and Ferretti, Stefania and Pozzo, Luigi Filippo Da and Roscigno, Marco and Calza, Stefano and Guerini, Agostino and Sigala, Sandra and Simeone, Claudio and Antonelli, Alessandro},
  title = {Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis)},
  journal = {Frontiers in Urology},
  year = {2022},
  doi = {10.3389/fruro.2021.796688}
}
Kostenlos starten →